Insights into Doublet Therapy and Clinical Trial Takeaways for Metastatic Prostate Cancer Treatment : Episode 2
Opinion
Video
Patient-Centered Approach to Use of Chemotherapy in Metastatic Prostate Cancer
Author(s):
The panelist discusses how incorporating chemotherapy into combination treatments for metastatic prostate cancer presents challenges such as increased resource requirements, the need for interdisciplinary collaboration, and potential inconveniences for patients, including more frequent clinic visits and laboratory monitoring.
Video Player is loading.
Video Content above is prompted by the following:
- What are some challenges of therapeutic combinations that include chemotherapy?
- Discuss the additional resources needed to use chemotherapy (eg, need for collaboration with a medical oncologist, access to an infusion center) and potential inconveniences for the patient (eg, additional clinic visits and laboratory monitoring).
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Immunotherapy in NMIBC: Key Results Safety Profile From BOND-003 Trial
Topline Data From the BOND-003 Trial in NMIBC
Data link incontinence severity to post-radical prostatectomy care
Jim Hu, MD, on upgrading of GG1 prostate cancer at radical prostatectomy
Expert discusses differentiating prostate cancer from age-related issues
Assessing Tolerability and Clinical Considerations in Abiraterone Formulation Selection
A 74-Year-Old Man With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Real-World Safety of Androgen Receptor Inhibitors in Nonmetastatic Castration-Resistant Prostate Cancer
Murilo De Almeida Luz, MD, on PSA and ALP changes with enzalutamide/radium-223
Remaining unmet needs in diverse populations with mHSPC
Related Content
